SORAFENIB 200MG TABLET

Sorafenib 200mg Tablet is a prescription anticancer medicine used in the treatment of advanced liver cancer (hepatocellular carcinoma), kidney cancer (renal cell carcinoma), and differentiated thyroid carcinoma. It is a targeted therapy that helps control tumor growth and improves patient outcomes under medical supervision.

Sorafenib belongs to the class of tyrosine kinase inhibitors (TKIs), which work by blocking signals that promote cancer cell growth and tumor blood vessel formation. By disrupting these pathways, sorafenib slows disease progression and reduces the ability of tumors to develop new blood vessels, limiting their growth.

Sorafenib 200 mg tablets should be taken strictly under the supervision of an oncologist. It is a cornerstone of targeted therapy for advanced cancers, offering patients a precision medicine option to manage disease while supporting overall treatment strategies.

Product Features

• Tyrosine kinase inhibitor (targeted cancer therapy)
• Used in liver, kidney, and thyroid cancer treatment
• Helps inhibit tumor growth and angiogenesis
• Oral tablet for convenient administration
• Suitable for long-term therapy as prescribed
• Prescription-only oncology medicine

How It Helps

• Blocks tyrosine kinases involved in cancer cell proliferation
• Inhibits angiogenesis, reducing tumor blood vessel formation
• Helps slow the growth and spread of liver, kidney, and thyroid tumors
• Supports long-term cancer management under oncologist supervision
• Oral formulation allows convenient daily dosing